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Mechanisms of Endothelial Cell Killing by 
H202 or Products of Activated Neutrophils 
PETER A. WARD, M.D., Ann Arbor, Michigan 
Interactions between rat pulmonary artery 
endothelial cells and hydrogen peroxide or 
toxic oxygen products from phorbol ester-acti- 
vated human neutrophils result in endothelial 
cell killing defined by ~lCr release. It has been 
shown that  this cytotoxic reaction can be 
blocked by the presence of catalase, iron chela- 
tors, or scavengers of the hydroxyl radical. 
Evidence shows that  products from xanthine 
oxidase of endothelial cells are necessary for 
the toxic effects of hydrogen peroxide or phor- 
bol ester-activated neutrophils. Addition of 
xanthine oxidase inhibitors protects against 
phorbol ester-mediated injury of endothelial 
cells. Preloading of endothelial cells with su- 
peroxide dismutase at tenuates injury caused 
either by hydrogen peroxide or phorbol ester- 
activated neutrophils.  Conversion of xanthine 
dehydrogenase to xanthine oxidase in endothe- 
lial cells occurs during contact of endothelial 
cells by activated neutrophils. This conversion 
is not related to oxygen products of neutro- 
phils. Conversion of xanthine dehydrogenase to 
xanthine oxidase in endothelial cells is also 
induced by endothelial cell contact with C5a, 
N'-formyl-methionyl-leucyl-phenylalanine 
(fMLP), or tumor  necrosis factor alpha 
(TNF~). Interaction of hydrogen peroxide with 
endothelial cells rapidly depletes adenosine tri- 
phosphate (ATP) and causes the extracellular 
appearance of xanthine and hypoxanthine. 
Agents that  protect endothelial cells from the 
toxic effects of hydrogen peroxide do not pre- 
vent falls in cellular ATP caused by hydrogen 
peroxide, indicating that  ATP levels do not 
necessarily correlate with cytotoxic events. A 
synergy between hydrogen peroxide and prote- 
ases in endothelial cell killing has been demon- 
strated. TNF~ causes alterations in endothelial 
cells, the result of which is increased suscepti- 
bility to killing by PMA-activated neutrophils. 
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I njury of endothelial cells by activated neutro- phils in vivo and in vitro is documented [1-6]. It 
appears that in vitro vascular endothelial cell killing 
by phorbol ester (PMA)-activated human neutro- 
phils is related to the formation of toxic oxygen 
products coming from the respiratory burst of the 
neutrophils. Since catalase, deferoxamine, and hy- 
droxyl radical (. OH) scavengers, such as dimethyl 
sulfoxide and dimethylthiourea, provide high de- 
grees of protection to endothelial cells both in vitro 
and in vivo [4], it is suggested that • OH may be a 
key factor in the injury of endothelial cell killing by 
activated neutophils. The inability of myeloperoxi- 
dase (MPO) inhibitors to protect against in vitro 
endothelial cell killing by activated neutrophils sug- 
gests that the halide-dependent products of hydro- 
gen peroxide (H202), such as hypochlorous acid 
(HOG), are not involved in the injury process [4], 
although it is suggested that HOC1 may play other 
roles, such as causing activation of the precursor 
forms of collagenase and gelatinase, the outcome of 
which would be breakdown of connective tissue 
matrix [7]. In this report, we review our own stud- 
ies, which suggest that a complex series of events 
are involved in killing of rat pulmonary artery en- 
dothelial cells by H202 or by products of activated 
neutrophils. 
PARTICIPATION OF XANTHINE OXIDASE IN 
ENDOTHELIAL CELL KILLING BY ACTIVATED 
NEUTROPHILS OR BY H202 
Recent experiments suggest that xanthine oxi- 
dase (XO) present within rat pulmonary artery 
endothelial cells plays a role in the killing of these 
cells by PMA-activated human neutrophils [8]. 
These endothelial cells (but not neutrophils) contain 
both XO as well as its precursor, xanthine dehydro- 
genase (XD). When three different inhibitors (allo- 
purinol, oxypurinol, and lodoxamide) of XO were 
present in the culture medium, there was a 29-64% 
reduction in endothelial cell killing reflected by 
their release of 51Cr (Table I). The protective ef- 
fects were dose dependent on the inhibitor present, 
showing the ability of these inhibitors to block the 
catalytic activity of endothelial cell XO [8]. If endo- 
thelial cells were pretreated with these inhibitors 
and then washed, the protective effects remained, 
whereas similar pretreatments of neutrophils did 
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TABLE I 
Ability of Xanthine Oxidase Inhibitors to Protect Endothelial 
Cells from Cytotoxicity Due to Activated Neutrophils 
Cytotoxicity (% Specific 
Interactions* Release of SZCr) Inhibition (%) 
None 32.7 + 1.7 - -  
AIIopurinot 12.8 -+ 2.1 60.8 
Oxypurinol 11.9 -+ 0.5 63.6 
Lodoxamide 23.1 -+ 1,1 293 
Data from [8]. 
*lnhibitors were used at a concentration of 5 raM. 
TABLE II 
Ability of Superoxide Dismutase (SOD) to Protect Endothelial 
Cells from Injury by H202 or Activated Neutrophils 
Injurious Agent 
SOD Activity Cytotoxicity 
Preloading in Endothelial (% Specific 
Concentrations Cells (Units/ Release of 
of SOD* 106 Cells) SlCr)t 
H202,100 #M None 12 -+ 2 45 -- 7 
H202, lO0 #M 2.0 rng 49 -+ 6 34 -+ 2 
H202, 100#M 5.0mg 168 + 13 24 -+ 6 
H202, 100 #M 10 rng 187 + 8 21 + 7 
Neutrophils, 0.8 x t06" None 18 -+ 2 
Neutrophils, 0.8 x 106t 10 mg 8 -+ 1 
*SOD, bovine CuZn-superoxide dismutase, containing 11,028 -+ 228 units/mg of protein. 
Human neutrophils were activated by addition of 100 ng/ml of phorbel myristate acetate. 
lData from [9]. 
not result in diminished endothelial cell killing (un- 
published data). These data provide support for the 
hypothesis that use of XO in endothelial cells is 
somehow linked to the ability of activated neutro- 
phils to kill these cells. 
Direct evidence for the role of superoxide anion 
(0~) in endothelial cell killing by H202 or PMA- 
activated neutrophils is shown in Table II. For 
these studies, neutrophils were incubated with 
varying concentrations of bovine CuZn-superoxide 
dismutase (SOD) for 18 hours, washed, and then 
exposed either to 100 t~M He02 or to 8 × 155 neu- 
trophils activated with PMA. The end points were 
5~Cr release from endothelial cells. Data show a 
progressive increase in the amount of SOD activity 
present in cell extracts, proportional to the amount 
of SOD to which the endothelial cells have been 
exposed. It is also apparent that there was progres- 
sive inhibition in the release of 51Cr subsequent to 
the addition of He02 as a function of the amount of 
SOD activity measurable in extracts of endothelial 
cells. Heat-inactivated SOD failed to provide any 
protection against H202-mediated killing [9]. As 
expected, the H202 preparation did not contain any 
measurable O~ (unpublished data), indicating that 
endothelial cells must be the source of the substrate 
for SOD. Also shown in Table II is the ability of 
endothelial cells, preloaded with SOD and exposed 
to PMA-activated neutrophils, to demonstrate 56% 
protection from killing because of increases in cellu- 
lar SOD. In conclusion, endothelial cell killing fol- 
lowing exposure either to H202 or PMA-activated 
neutrophils involves endothelial cell-derived 0~. It 
is believed that 0~-. is produced from XO of the 
endothelial cell. 
CONVERSION IN ENDOTHELIUM OF XANTHINE 
DEHYDROGENASE TO XANTHINE OXIDASE 
Studies provide evidence that conversion in en- 
dothelial cells of XD to XO occurs by contact of en- 
dothelial cells with PMA-activated neutrophils [8]. 
This conversion process is irreversible (XO does 
not revert  to XD following addition of reducing 
agents). Figure 1 shows that agents (catalase, 
deferoxamine) that prevent endothelial cell killing 
by PMA-activated neutrophils [4] and SOD failed to 
interfere with the conversion of XD to XO. In this 
experiment, the percent of total activity (XD and 
XO) due to XO was approximately 40% when non- 
activated neutrophils (PMNs) were present, rising 
to nearly 70% when PMA stimulated the neutro- 
phils. These data suggest that oxygen products of 
activated neutrophils do not account for the conver- 
sion of XD to XO in endothelial cells, supported by 
data in Figure 2 in which PMA4reated neutrophils 
from a normal human donor and from a patient with 
chronic granulomatous disease of childhood (CGD) 
were used. Neutrophils from the patient donor are 
unable to exhibit a respiratory burst after addition 
of PMA and do not form H202 or 0~-. Figure 2 
shows no difference in the conversion of XD to XO 
when results from the two cell donors are com- 
pared, indicating that the XD "converting factor" of 
the activated neutrophil is not related to an oxygen 
product. 
Table III shows that conversion of XD to XO oc- 
curs because of endothelial cell interaction with cer- 
tain peptide mediators [10]. For the conversion pro- 
cess, the EDso is shown for the compounds listed in 
Table III. Human C3a was inactive, but human re- 
combinant C5a was highly active, with an EDso of 4 
riM. Enzymatic removal of the C-terminal arginine 
abolished the activity of C5a. The synthetic chemo- 
tactic peptide, N ' - formyl-Met-Leu-Phe  (fMLP), 
and recombinant human tumor necrosis factor 
(TNFa) showed activity, but not recombinant 
human interleukin-lfi (IL-lfi) or bradykinin, which 
are reactive with endothelial cells [11-13]. Finally, 
phorbol ester (PMA) did not convert XD to XO. 
These findings demonstrate that certain chemotac- 
tic peptides can directly interact with endothelial 
cells and be functional. The mechanism is not clear, 
but the conversion process of XD to XO was rapid 
(complete within 5-10 minutes) and was irreversi- 
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Figure 1. Percent xanthine oxidase (X0) activity 
present as combined catalytic activity of xan- 
thine dehydrogenase {XD) and X0. Human neu- 
trophils alone or in the presence of phorbol 
ester (PMA) were present in association with 
monolayers of rat pulmonary artery endothe%l 
cells. After 4 hours, the cell monolayers were 
harvested and extracted. XD and X0 were mea- 
sured and the percent of total activity present as 
X0 calculated. The data demonstrate that none 
of the interventions used [catalase, superoxide 
dismutase (SOD), and deferoxamine] blocked 
the conversion of XD to X0 in endothelial cells 
exposed to phorboi ester*activated neutrophils. 
PMN: nonactivated neutrophils. 
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Figure 2. Comparison of the abilities of acti- 
vated normal neutrophils and activated neutro- 
phils from a patient with chronic granulomatosis 
disease of childhood (CGD) to convert XD to X0 
in rat pulmonary artery endothelial ce]ls. As evi- 
dent from the data, the amount of conversion 
occurring with activated normal neutrophils was 
the same as the amount of conversion occurring 
with activated CGD neutrophils. Hence, the con- 
verting factor cannot be linked to an oxygen 
product. PMN: nonactivated neutrophils. 
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ble [10]. These findings suggest that a change in the 
ratio of XD to XO in favor of XO places the endo- 
thelial cell at risk of injury, especially in the pres- 
ence of H202 or activated neutrophils. 
RELATIONSHIP OF ENDOTHELIAL CELL ATP AND 
INJURY PRODUCED BY H202 
It is known that any type of cell injury results in 
loss of ATP levels within the affected cell [14-16]. 
In the endothelial cells, the fall in ATP after expo- 
sure has been postulated due to loss of ATP synthe- 
sis through inactivation of an enzyme in the Krebs 
cycle [14], associated with cell injury or death. 
Table IV addresses the following question: Does 
H202-induced loss of ATP correlate with cell death 
measured by 5]Cr release? For these experiments, 
endothelial cells were loaded with [14C] adenosine, 
the bulk being converted to ATP, providing a radio- 
active pool for monitoring [17]. These studies mea- 
sured the breakdown of the existing pool of [14C] 
ATP. The experiments were carried out in the pres- 
ence or absence of three agents (deoxycoformycin, 
allopurinol, and deferoxamine) providing 46-95% 
protection against H202-induced cytotoxicity (Table 
IV). Exposure of endothelial cells to H202 reduced 
[14C] ATP by 72%. This reduction in ATP occurred 
within the first 20-30 minutes after addition of 
H202, and ATP levels remained at the reduced level 
for several hours. In all cases when cells were ex- 
posed to H202, there were significant amounts of 
xanthine (X) and hypoxanthine (HX) in the extra- 
cellular fluid (Table IV). These levels reduced by 
nearly one-half (to 9%) in the presence of 
deoxycofo~ycin,  an adenosine deaminase inhibi- 
tor. Deoxycoformycin increased levels of cellular 
adenosine monophosphate (AMP). The remarkable 
aspect of these data was the fact that there was 
little or no sparing effect in levels of ATP by agents 
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TABLE III 
Structure-Function Specificity of Peptides in Conversion of 
Xanthine Dehydrogenase (XD) to Xanthine Oxidase (XO) in 
Endothelial Cells 
EDso for Conversion 
Material Used of XD to XO 
C3a >5 #M 
C5a 4 nM 
C5a desarg >1 #M 
fMLP 46 nM 
TNFG 12 nM 
IL-I~ >10 units 
Bradykinin >10 #M 
PMA >10 #M 
Data from [I0]. 
providing high degrees of protection against the 
cytotoxic effects of H202. The protective effects of 
deferoxamine, allopurinol, and deoxycoformycin 
are not related to maintaining high cellular levels of 
ATP in H202. 
SYNERGY BETWEEN PROTEASES AND H202 IN 
ENDOTHELIAL CELL CYTOTOXICITY 
Although antiproteases, such as soybean trypsin 
inhibitor, do not protect endothelial cells against in 
vitro cytotoxic effects of PMA-stimulated neutro- 
phils [4], it is likely that proteases and toxic oxygen 
products from neutrophils may jointly contribute to 
cytotoxic effects of activated neutrophils on vascu- 
lar endothelial cells. There could also be synergistic 
effects of H202 and protease on matrix substances, 
such as vascular basement membrane. Table V 
shows that compared with H202-induced cytotoxic- 
ity of endothelial cells, there is a synergy between 
protease actions and He02 effects. The experiments 
involved an end point of 18 hours during which the 
cytotoxic effects of H20e were observed [18]. Cells 
were exposed to 0.1 mM H202 for 18 hours, prote- 
ase for 18 hours, or to both (protease for the first 2 
hours, and then addition of H202 and termination of 
the experiment at 18 hours). Table V shows that, 
regardless of which of the three proteases was 
used, there was limited cytotoxicity with cell expo- 
sure either to H202 or to protease; the dual expo- 
sure of endothelial cells to protease and H202 re- 
sulted in cytotoxicity, which increased in a syner- 
gistic manner. The mechanisms of these synergistic 
cytotoxic effects are not known, but data show that 
alteration of endothelial cells by exposure to prote- 
ase exposes them to intensified injury by the addi- 
tion of H202. Whether or not exposure to H202 in- 
creases the permeability of endothelial cells and 
permits entry of the proteases with resulting prote- 
olytic conversion of XD to XO is a possible explana- 
tion for the effects. 
ENHANCEMENT OF NEUTROPHIL-MEDIATED 
CYTOTOXICITY OF ENDOTHELIAL CELLS BY 
TUMOR NECROSIS FACTOR ALPHA 
It is known that exposure of endothelial cells to 
cytokines, such as TNFa or IL-1/3, results in a 
time-dependent (requiring several hours) and a cy- 
cloheximide-sensitive change related to increased 
adherence of human neutrophils to the cytokine- 
altered endothelial cells [13]. We analyzed the ex- 
tent to which TNFa may induce other functional 
changes in endothelial cells, such as increased sen- 
sitivity to the cytotoxic effects of activated neutro- 
phils. Endothelial cells were exposed to human re- 
combinant TNFa for 5 or 18 hours, washed, and 
then neutrophils added followed by addition of 
PMA. Cytotoxicity was measured after 4 hours 
[19]. Table VI shows that in endothelial cells not 
treated with TNFa,  PMA-activated neutrophils 
caused 17% cytotoxicity. With prior exposure of 
endothelial cells to TNFa for 18 hours followed by 
washing and addition of neutrophils, but in the ab- 
sence of PMA, cytotoxicity was negligible (2%). If 
endothelial cells were exposed to TNFa for 5 to 18 
hours, subsequent addition of PMA-activated neu- 
trophils resulted in cytotoxicity ranging from 31- 
41%. Use of heat-inactivated TNFa (100°C for 20 
TABLE IV 
Changes in Endothelial Cell ATP in Presence or Absence of Protective Agents 
Metabolite (% of Total Radioactivity) 
Cellular 
Condition* Intervention1" Protection (°/o)$ ATP AMP X/HX ATP 
Extracellular 
AMP X/HX 
Buffer None - -  60 _+ 13 3 "- 3 <1 <1 
H202 None 0 17 _+ 7 4 ± 1 3 ± 1 <1 
H202 Deferoxamine 95 -+ 3 23 "- 11 3 -- 1 2 _+ 1 <1 
H202 AIIopurinol 65 _+ 10 24 -- 2 3 _+ 1 5 _+ 3 <1 











*When present, 0.5 mM H202 was used. ATP and related metabolites were measured 30 minutes after addition of H202. 
tCeBcentrations of protective drugs employed were 1 mM in each case. 51 :]:Defined as percentage reduction in specific release of Cr from endothelial cells 4 hours after addition of H202. 
Adapted from [17]. 
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TABLE V 
Synergy Between Proteases and H202 in Endothelial Cell 
Killing 
Material Added to Cytotoxicity (% Specific 
Experiment Endothelial Cells* Release of SlCr)l" 
A H202 (0.1/~M) 33 -+ 1 
Pancreatic elastase (2.3 units) 13 _+ 1 
Both 75 + 2 
B H202 44 + 4 
Cathepsin (2.5 #g) 5 + 2 
Both 76 + 1 
C H202 23 -+ 2 
Chym0tpjpsin (3.0 units) 5 + 1 
Both 48 -+ 3 
*Cells were exposed to H202 and/or to protease for 18 hours, following which 51Cr 
release was measured. When both reagents were present, H202 was added, followed by 
addition later. , of protease 2 hours 
TData from [I8]. 
TABLE Vl 
Ability of TNFoz to Enhance Endothelial Cell Killing by 
Activated Human PMNs* 
Pretreatment of Cytotoxicity 
Endothelial Cells Neutrophil Treatment (% Release of 51Cr) 
None None <1 
None PMA (i00 ng/ml) 17 -+ 5 
TNFe, 18 hours (50 ng/m[) None 2 + 1 
TNFe, 5 hours PMA 3i -+ 5 
TNFe, 18 hours PMA 41 -+ 6 
TNFa, 18 hours heat PMA 19 +- 5 
inactivated 
None TNF~ (30 minutes 12 -+ 7 
pretreated, followed 
by PMA) 
*Results from [19]. 
minutes) abolished the ability of the cytokine to 
modify endothelial cells, rendering them more sen- 
sitive to the cytotoxic effects of PMA-activated 
neutrophils. Addition of TNFa to the neutrophils 
followed by their washing and addition of PMA did 
not increase endothelial cell killing [19]. 5~Cr re- 
lease from endothelial cells was reduced from 17% 
to 12%, apparently due to a "deactivation" of the 
neutrophils. 
These data show that cytokine-induced changes 
of endothelial cells render these cells more suscepti- 
ble to the injurious effects of PMA-activated neu- 
trophils. It has also been shown that, under these 
conditions, the bulk of the cytotoxic effects of acti- 
vated neutrophils can be blocked either by catalase 
or deferoxamine [19]. The mechanism of increased 
cytotoxicity, due to activated neutrophils, appar- 
ently operates through the same pathway normally 
used when PMA-activated neutrophils are in con- 
tact with endothelial cells not pretreated with 
TNFa. 
Data in this review show that, in the interaction 
between activated neutrophils and endothelial 
cells, endothelial cells are not passive partners in 
the events leading to cytotoxicity. Endothelial cell 
generation of O~ • is apparently a key event result- 
ing in cytotoxicity following exposure to PMA- 
activated neutrophils (or after exposure to H202). 
In rat pulmonary endothelial cells, 0~- is apparently 
derived from XO, and its activity is increased by 
endothelial cell contact with PMA-activated neutro- 
phils or by contact with chemotactic mediators such 
as C5a, TNFa, or fMLP. The main role of H202 
may be to break down ATP, such that the sub- 
strates for XO (xanthine and hypoxanthine) become 
available. Apparently, • OH causes maximal dam- 
age resulting in cytotoxic changes in endothelial 
cells, although debate surrounds whether - OH is a 
product of the Fenton reaction or derived from a 
more recently described interaction between 0~-. 
and nitric oxide [20]. The findings of the synergy 
between proteases and H202 in endothelial cell kill- 
ing suggest other mechanism(s), showing endothe- 
lial cell killing by neutrophils and their products. 
These observations provide new insights into the 
multiple steps associated with cytotoxic events in 
endothelial cells because of their contact with acti- 
vated neutrophils. The data suggest new therapeu- 
tic approaches for the protection of vascular endo- 
thelial cells in acute inflammatory reactions. 
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